Healthcare giant Pfizer ( PFE 2.24%) has been offering a high yield for some time. But that hasn't been enough to get ...

Pfizer offers strong dividends, solid cash flow coverage, discounted value and key risks from patent cliffs, pricing and ...

Consider buying Medtronic for its dividend and Pfizer for its turnaround potential if you are looking for attractive ...

Discover why Pfizer stock may be set for a bull run by 2026 with key wins, strong Q3 earnings, and growth drivers.

When the AI bubble bursts, Altria will shine again. It has paid out billions in dividends over the years, and that is ...

Now, it’s worth noting Stock Advisor’s total average return is 1,035% — a market-crushing outperformance compared to 191 % ...

Wyeth was a bigger deal, but with Pfizer's payout ratio so high, there isn't much wiggle room for the dividend. In other ...

Pfizer PFE stock has been trading above its 50-day moving average since early November, indicating a potential short-term ...

On November 13, 2025, Pfizer completed its acquisition of Metsera, Inc., a Delaware-based company, for approximately $7.0 billion. The acquisition includes contingent value rights for additional ...

ICICI Securities is bullish on Pfizer has recommended buy rating on the stock with a target price of Rs 6100 in its research ...

Learn more about whether Aurinia Pharmaceuticals Inc. or Zai Lab Limited is a better investment based on AAII's A+ Investor ...

Harvest's Paul MacDonald sees healthcare's deep valuation discount and long-term fundamentals setting the stage for renewed ...